| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	Clinical evaluation of the product by design surgeons completed, driving early commercial momentum
																	FDA cleared and U.S. manufactured implant system positions SINTX to enter billion-dollar U.S. market SALT LAKE CITY, Utah, Oct....
																	SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics innovator specializing ...
																	SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics innovator specializing ...
																	-SEC Filing
																	Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and lowers the price target from...
																	SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics innovator specializing ...
																	Significant Development in the Estimated $30 Billion Global Infection-Prevention Market
																	https://www.sec.gov/ix?doc=/Archives/edgar/data/0001269026/000149315225012731/form8-k.htm